Diabetic Foot Ulcer Prevention Through Workplace Wellness Programs
Conceptual Perspective
DOI:
https://doi.org/10.32890/ssmj2024.1.2.4Keywords:
Diabetic foot ulcer, non-communicable diseases, prevention, wellness program, lifestyleAbstract
Diabetes Mellitus in one of non-communicable disease (NCDs) and is a major public health problem in Malaysia, especially type 2 diabetes. International Diabetes Federation in 2019 reported, 463 million people infected with diabetes, projected to infect 578 million and 700 million of people by the year 2030 to 2045. One of the complications from DM were Diabetic Neuropathy, a nerve damage that can causes numbness, pain, and weakness, especially in the legs and feet. Diabetes Foot Ulcers (DFU) are a major complication in DM patients. Diabetic foot ulceration is a devastating complication of diabetes that is associated with infection, amputation, and death, and is affecting increasing numbers of patients with diabetes mellitus. Thus, this paper explores the conceptual framework for preventing DFUs through workplace wellness programs, emphasizing the integration of health education, risk factor management, and supportive environments. Workplace wellness initiatives can play a crucial role in educating employees about foot care practices, encouraging regular foot inspections, and promoting appropriate footwear. Key strategies include continuous education on glycemic control, lifestyle modifications, and the importance of early intervention for risk factors such as peripheral neuropathy and vascular disease. By fostering a culture of health and wellness in the workplace, organizations can significantly reduce the incidence of DFUs and improve overall employee health outcomes.
References
Ahmad A.C. (2024). Holistic management of diabetic foot: Redefining strategy. IIUM Medical Journal Malaysia, 23(3), 1-3.10.31436/imjm.v23i03.2656
American Diabetes Association. (2018). Economic costs of diabetes in the U.S. in 2017. Diabetes Care, 41(5),917–928. doi: 10.2337/dci18-0007. doi
American Diabetes Association. (2023). Standards of medical care in diabetes. Diabetes Care, 46(Supplement 1), 1-291.
Armstrong, M.J., Gaunt, P., Aithal, G.P., Barton, D., Hull, D., Parker, R., Hazlehurst, J.M., Guo, K., LEAN trial team, Abouda, G., Aldersley, M.A., Stocken D., Gough, S.C., Tomlinson, J.W., Brown, R.M., Hübscher, S.G., & Newsome, P.N. (2016). Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): A multicentre, double-blind, randomised, placebo-controlled phase 2 study. Lancet, 387(10019),679-690. doi: 10.1016/S0140-6736(15)00803-X.
Cusi, K., Isaacs, S., Barb, D., Basu, R., Caprio, S., Garvey, W.T., Kashyap, S., Mechanick, J.I., Mouzaki. M., Nadolsky, K., Rinella, M.E., Vos, M.B., & Younossi, Z. (2022). American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of non-alcoholic fatty liver disease in primary care and endocrinology clinical settings: Co-sponsored by the American Association for the study of liver diseases (AASLD). Endocrine Practice, 28(5), 528-562. https://doi.org/10.1016/j.eprac.2022.03.010
Cusi, K., Orsak, B., Bril, F., Lomonaco, R., Hecht, J., Ortiz-Lopez, C., Tio, F., Hardies, J., Darland, C., Musi, N., Webb, A., & Portillo-Sanchez, P. (2016). Long-term pioglitazone treatment for patients with non-alcoholic steatohepatitis and prediabetes or type 2 diabetes mellitus: A randomized trial. Annals of Internal Medicine, 165(5), 305-315. https://doi.org/10.7326/M15-1774
Davies, M. J., Aroda, V. R., Collins, B. S., et al. (2022). Management of hyperglycemia in type 2 diabetes, 2022: A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 45(11), 2753-2786. https://doi.org/10.2337/dci22-0034
Endocrine Society. (n.d.). Clinical practice guidelines: Provides guidelines on evaluation and management of patients with diabetes as well as links to other information for clinicians. https://www.endocrine.org/clinical-practice-guidelines
Holt, R.I.G., DeVries, J.H., Hess-Fischl, A., Hirsch, I.B., Kirkman, M.S., Klupa, T., Ludwig, B., Nørgaard, K., Pettus, J., Renard, E., Skyler, J.S., Snoek, F.J., Weinstock, R.S., & Peters A.L. (2021). The management of type 1 diabetes in adults: A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia, 64(12), 2609–2652. https://doi.org/10.1007/s00125-021-05568-3
International Diabetes Federation. (2017). IDF diabetes atlas (8th ed.). Brussels. Institute for Public Health (IPH), Ministry of Health Malaysia. (2020). National health and morbidity survey (NHMS) 2019: Vol. I: NCDs – Non-communicable diseases: Risk factors and other health problems. http://iku.gov.my/nhms-2023
Lee, Y.H., Cho, Y., Lee, B.W., Park, C.Y., Lee, D.H., Cha, B.S., & Rhee, E.J. (2019). Non-alcoholic fatty liver disease in diabetes. Part I: Epidemiology and diagnosis. Diabetes & Metabolism Journal, 43(1), 31-45. https://doi.org/10.4093/dmj.2019.0011
Newsome, P.N., Buchholtz, K., Cusi, K., Linder, M., Okanoue, T., Ratziu, V., Sanyal, A.J., Sejling, A.S., & Harrison, S.A. (2021). A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis. New England Journal of Medicine, 384(12), 1113-1124. https://doi.org/10.1056/NEJMoa2028395
Patel Chavez, C., Cusi, K., & Kadiyala, S. (2022). The emerging role of glucagon-like peptide-1 receptor agonists for the management of NAFLD. Journal of Clinical Endocrinology & Metabolism, 107(1), 29-38. https://doi.org/10.1210/clinem/dgab578
Perkeso introduces enhanced health screening. (2023, June 7). The Star. https://www.thestar.com.my/news/nation/2023/06/07/perkeso-introduces-enhanced-health screening
Powers, M.A., Bardsley, J.K., Cypress, M., Funnell, M.M., Harms, D., Hess-Fischl, A., Hooks, B.D., Mandel, E.D., Maryniuk, M.D., Norton, A., Rinker, J., Siminerio, L.M., & Uelmen, S. (2020). Diabetes self-management education and support in adults with type 2 diabetes: A consensus report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association. Diabetes Care, 43(7), 1636-1649. https://doi.org/10.2337/dci20-0023
Promoting healthy workforce in Malaysia. (2023, May 31). The Star. https://www.thestar.com.my/news/nation/2023/05/31/promoting-healthy-workforce-in-malaysia
Published
Issue
Section
License
Copyright (c) 2024 amirulafizan mohdbidin, Niu Soon Yen, Annuar Aswan Mohd Noor
This work is licensed under a Creative Commons Attribution 4.0 International License.
